Trading Statement ADVANCED HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2013/059246/06) (“the Company” or “the Group” or “Advanced Health”) ISIN Code: ZAE000189049 JSE Code: AVL TRADING STATEMENT In terms of paragraph 3.4(b) of the Listings Requirements of the Johannesburg Stock Exchange, listed companies are required to publish a trading statement as soon as they become reasonably certain that the financial results for the next period to be reported on will differ by more than 20% from those of the previous corresponding period. Shareholders are advised that Advanced Health expects an increase in the loss and headline loss per share, attributable to the parent, for the 12 months ending 30 June 2017, of at least 100% compared to the loss per share and headline loss per share of 8.26 and 8.25 cents respectively for the 12 months ended 30 June 2016. The increase in losses are planned and in accordance with the Company rolling out its known strategy to become the leading provider of day hospitals in South Africa and Australia. In South Africa, the Group now consists of ten operational day hospitals and three in Australia. The Company is starting to see an increase in the number of patients treated and consequently turnover in both South Africa and Australia is increasing. The information in this trading statement has not been reviewed and reported on by the Company’s auditors. EXPANSION IN AUSTRALIA Shareholders are hereby advised that the Australian subsidiary of Advanced, Presmed Australia (PMA) has reached an agreement in principle with the owner of an ophthalmic day hospital to acquire 100% of the business. Presmed Australia has signed an agreement for the purchase of this facility. As part of the agreement the current owner has to satisfy a number of conditions precedent for the sale to be completed, which is scheduled to take place on or about 3 July 2017. The acquired facility is a one theatre ophthalmic specific day hospital situated in the heart of the business district in the suburb of Hornsby, 25 kilometres north-west of Central Sydney. The Facility is licensed, has contracts in place with the majority of medical schemes, has accreditation with Global Mark, and is in very good condition. The facility is located adjacent to one of Sydney’s largest shopping centres. It’s added strength of location is that it is within 200 meters of all the Hornsby based Ophthalmologists consulting rooms. PMA are excited for the opportunity that this facility presents to be part of the Group and to be a leading Day Hospital in the greater Hornsby area. Johannesburg 8 June 2017 Designated Advisor Grindrod Bank Limited Date: 08/06/2017 12:16:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.